The UK Medical Research Council are collaborating with AstraZeneca to benefit researchers of Alzheimers, cancer & rare disease
The Medical Research Council (MRC) has granted £7 million of funding for 15 research projects through its groundbreaking collaboration with AstraZeneca, which gave academic researchers unprecedented access to 22 chemical compounds. Scientists will use the compounds to study a broad range of conditions from common diseases like Alzheimers, cancer and lung disease through to rarer conditions such as motor neurone disease and muscular dystrophies.